We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Semiconductor Technology Revolutionizes DNA Sequencing

By LabMedica International staff writers
Posted on 01 Apr 2012
A latest generation, semiconductor based DNA sequencing system is expected to reduce the time required to produce a complete human gene to less than one day while costing less than USD 1000.

The Ion Torrent division of Life Technologies Corporation (Carlsbad, CA, USA) recently announced the launch of its benchtop Ion Proton Sequencer. More...
This instrument, which is based on the next generation of semiconductor sequencing technology, will be priced initially at less than USD 150,000, putting it within the reach of many more laboratories than the current USD 500,000 to USD 750,000 systems on the market today.

Ion Torrent’s technology directly translates chemically encoded information into digital information on a semiconductor chip in an approach that marries simple chemistry to proprietary semiconductor technology. The result is a sequencing technology that is simpler, faster, more cost effective, and scalable than any other technology currently available.

Ion Torrent technology can be adapted to cover any sequencing application. The Ion PGM Sequencer was designed for sequencing genes, small genomes, panels of genes, or performing gene expression profiling. The Ion Proton Sequencer is ideal for sequencing both exomes and human genomes.

“Just six months after our first semiconductor sequencing chip was released, people used it to help solve the German E. coli outbreak, sequencing the toxic strain in just a couple of hours,” said Dr. Jonathan M. Rothberg, CEO of Life Technologies Corporation’s Ion Torrent division. “Now, six months later we are developing a chip that is 1,000 times more powerful than that to sequence an entire human genome in about the same amount of time. That is the power that semiconductors bring to sequencing.”

Related Links:

Life Technologies Corporation




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Test Reader
DIA5000
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.